Paragon 28 ROE 2020-2022 | FNA

Current and historical return on equity (ROE) values for Paragon 28 (FNA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Paragon 28 ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2022-06-30 $-0.03B $0.18B -20.76%
2022-03-31 $-0.02B $0.19B -21.95%
2021-12-31 $-0.01B $0.19B -25.93%
2021-06-30 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.384B $0.147B
Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.023B 21.80
Edwards Lifesciences (EW) United States $54.208B 38.35
Alcon (ALC) Switzerland $30.150B 25.53
STERIS (STE) Ireland $17.307B 21.50
Teleflex (TFX) United States $9.641B 15.36
Fresenius Medical Care AG KGaA (FMS) Germany $8.287B 7.64
Penumbra (PEN) United States $7.435B 891.96
Globus Medical (GMED) United States $6.225B 31.75
Glaukos (GKOS) United States $2.693B 0.00
Integer Holdings (ITGR) United States $2.196B 17.17
Nevro (NVRO) United States $1.739B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.081B 16.55
Artivion (AORT) United States $0.519B 49.50